Costs to farmers of a tuberculosis breakdown

An on-farm survey of 151 cattle farmers who had experienced a bovine tuberculosis (Mycobacterium bovis) breakdown on their farms was undertaken in 2003 to assess the costs associated with the breakdown. In 90 per cent of cases the cost was estimated to be less than 18,513 pounds sterling for dairy herds and less than 11,462 pounds sterling for beef herds, but with a range from 229 pounds sterling to 103,817 pounds sterling. The main cost was the slaughter of reactor cattle. For the majority of the farmers, the compensation payments seemed to meet most of the costs of their breakdowns, although a majority was still left with net losses.     

Financial benefit from the eradication of swine dysentery

Swine dysentery was eradicated from a 270 sow herd by using medication in conjunction with cleaning and disinfection, without reducing the herd size. The feed conversion efficiency, cost per kg liveweight gain and veterinary costs in the herd were compared with similar Meat and Livestock Commission recorded herds before swine dysentery entered the farm, while it was present and after its eradication. During the four years when the disease was endemic in the herd the feed conversion efficiency deteriorated by 0.58, equivalent to 7.31 pounds per pig, the cost per kg liveweight gain was 15 per cent higher and the costs of veterinary care and medicines were 1.38 pounds per pig greater. Although there were pigs with clinical swine dysentery in the herd during the four year period, the poor production figures were attributed mainly to subclinical disease. The cost of eradicating the disease was more than 20,000 pounds but this sum was recouped within 12 months by the improved production and reduced drug usage. The chances of success of such a programme have been estimated to be between 54 and 90 per cent.     

Incidence of lameness in dairy cows

A survey of the number of treatments for lameness in 21,000 dairy cows from 185 herds in the University of Edinburgh/Dalgety Spillers dairy herd health and productivity service in England and Wales showed an average incidence of cases of 25 per cent. Veterinary surgeons treated 6.3 per cent and farmers 18.7 per cent and 1.4 per cent of cows were culled because of lameness. Monthly and regional variations were recorded. An assessment of the economic effects suggested that the average annual cost in a 100 cow herd was 1175 pounds with an overall cost to British farmers of more than 35 million pounds. The economic importance is such that research into specific factors affecting foot health should be carried out. Meanwhile, a broad approach to prevention and control of lameness on farms is recommended under the general headings of management/environment, nutrition and breeding.     

Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales

A survey of clinical and subclinical mastitis was carried out on 97 dairy farms in England and Wales, selected at random from members of a national milk recording scheme. The farmers were asked to collect aseptic milk samples from five consecutive cases of clinical mastitis and from five quarters with high somatic cell counts using a defined protocol, and they completed a questionnaire that included information on the cows sampled, the herd and the history of mastitis in the herd. The samples were collected throughout the year. The mean incidence of clinical mastitis was 47 cases per 100 cows per year (estimated from historic farm records) and 71 cases per 100 cows per year (estimated from the samples collected). Streptococcus uberis and Escherichia coli were isolated in pure culture from 23.5 per cent and 19.8 per cent, respectively, of the clinical samples; 26.5 per cent of the clinical samples produced no growth. The most common isolates from the samples with high cell counts were coagulase-negative staphylococci (15 per cent), S uberis (14 per cent) and Corynebacterium species (10 per cent). Staphylococcus aureus and coagulase-positive staphylococci together accounted for 10 per cent of the samples with high somatic cell counts; 39 per cent produced no bacterial growth.     

Comparison of early season suppressive anthelmintic prophylactic methods for parasitic gastroenteritis and bronchitis in calves

A comparison was made of the material costs and effectiveness of three methods of early season suppression by anthelmintic medication of Ostertagia species and two of Dictyocaulus viviparus in calves, each method suppressing faecal egg output for different lengths of time from the start of spring grazing. The anthelmintics used were: Morantel bolus administered five days before going to grazing; oxfendazole given three times at three, six and nine weeks after the start of grazing and ivermectin injected three, eight and 13 weeks after going to pasture. The effectiveness of each was estimated by comparison with worm numbers in untreated control calves. Oxfendazole, which was active for the shortest time (about 65 days) from the start of grazing (May 1), produced a 78.1 per cent reduction in Ostertagia species and an 84.4 per cent reduction in D viviparus. The morantel bolus was estimated to be active for 90 days and resulted in a 94.3 per cent reduction of Ostertagia species. The ivermectin treatment, which, because of the prolonged excretion of the chemical and different sensitivity of worm species, was estimated to suppress Ostertagia species for 105 days and D viviparus for 119 days, caused reductions of 98.7 per cent of the former and 97.4 per cent of the latter species. Material costs per calf were estimated at pounds 1.25 for oxfendazole, pounds 2.00 for ivermectin and pounds 10 for the morantel bolus.     

Estimated direct economic costs associated with tick-borne diseases on cattle in Tanzania

Tick-borne diseases, namely, anaplasmosis, babesiosis, cowdriosis and theileriosis, constrain cattle production and improvement in Tanzania, leading to considerable economic losses. A simple spreadsheet model was used to estimate the economic losses resulting from production losses, treatment and control costs associated with tick-borne diseases (TBD) in Tanzania. Model parameters included the national cattle population, reported TBD morbidity, fatality risk, and chemotherapy and control measures used. The total annual national loss due TBD was estimated to be 364 million USD, including an estimated mortality of 1.3 million cattle. Theileriosis accounted for 68% of the total loss, while anaplasmosis and babesiosis each accounted for 13% and cowdriosis accounted for 6% of the total loss. Costs associated with mortality, chemotherapy and acaricide application accounted for 49%, 21% and 14% of the total estimated annual TBD losses, respectively, infection and treatment method milk loss and weight loss accounted for 1%, 6% and 9% of the total annual loss, respectively. Despite the inadequacies of the data used, the results give evidence that tick-borne diseases inflict substantial economic losses on cattle production and resource use in Tanzania.     

A survey of cattle tick control practices in the eastern Cape Province of South Africa.

Current cattle tick control practices and producer attitudes towards tick control in the eastern Cape Province of South Africa are discussed. These were ascertained from answers to a questionnaire survey to which 31.2% of farmers responded. In general, producers favoured intensive tick control. Beef and dairy farmers had a definite preference for synthetic pyrethroid acaricides, the majority followed a 25 times p.a. treatment frequency and most changed acaricides because of price. Beef producers favoured pour-on application of acaricides while the majority of dairy producers utilized plunge dipping. Producers who used hand spray techniques experienced the highest percentage of confirmed acaricide resistance. A costs of R11.27 for acaricide treatment per bovine per annum was calculated from data gained in this survey. A cost index of 2,496 was calculated by relating acaricide cost to the prevailing price of beef in the region. Only a small number of producers used heartwater, babesiosis and anaplasmosis vaccines. Relative tick borne disease mortality ratios indicated higher heartwater mortalities at high acaricide treatment frequencies. These results are discussed in relation to the tick control regimes practised.     

Economic evaluation of the production impact of bovine schistosomiasis and vaccination in the Sudan

This study was done to evaluate the estimated economic consequences of the recent discovery that an irradiated Schistosoma bovis vaccine was effective in reducing mortality and intensity of infection in cattle after field exposure to S. bovis in the White Nile province. The benefits and costs were hypothesized to occur over a 5-year period starting after the vaccine had been further developed to optimal commercial usefulness.

The potential benefits of vaccination are from the avoidance of mortality and growth delay losses caused by S. bovis infection and were based on an owner survey conducted in 1981. These benefits were discounted from the time of their potential marketing opportunity to the first year of a vaccination program at 15% per annum and were valued on a basis of 1982 prices for live cattle exported to Egypt and Saudi Arabia. Variations in benefits stem from degree of infection probability, mortality and morbidity estimates and percent of animals vaccinated. Since clinical schistosomiasis (“gorag” — sunken-eyed appearance) and associated production losses occur almost exclusively in 6- to 30-month-old cattle, and there is evidence for long-term immunity, vaccinations would be given to cattle in this age-specific group or younger once in their lifetime. The principal variation in vaccination program costs, also valued at 1982 prices, is from vaccine production costs; $0.50 or $4.00 per dose. A vaccine efficacy of 70%, observed in a previously reported field trial, was used in these calculations.

Present value benefit—cost (b–c) ratios were estimated for the central, western and southern areas for high- and low-level effects of S. bovis impact on production and the vaccination program, cost and effectiveness. In an area (central provinces) of high infection probability (90%), high percentage of animals vaccinated (90%), high mortality (7.1%), and low vaccine production costs, the b–c ratio was 12.7. In contrast, a b–c ratio of 0.7 was estimated for an area (southern provinces) assuming low infection probability (50%), low percent of animals vaccinated (50%), lower mortality (3.55%) and high vaccine production costs. Potential returns from increased future milk and calf production and from faster herd build-up with younger females were not included in these benefit calculations. These results indicate that under most conditions further development of the vaccine and cost-effective vaccine production techniques would yield very favorable returns from improved livestock production efficiency in the Sudan. Export prices were assumed to not vary significantly with increased supply of export-quality cattle resulting from the estimated production losses avoided by vaccination against schistosomiasis.     

Economic and reproductive consequences of retained placenta in dairy cattle

The financial losses due to retained placenta in Dutch dairy cattle were estimated by using two different methods of calculation. A data-set containing the birth records of 160,188 Meuse-Rhine-Yssel cows provided data on the reproductive performance of cows with and without retained placenta. The fertility of cows after retention of the placenta appeared to be affected. An economic calculation made by adding the losses due to increased calving interval, increased culling rate, loss of milk production and the costs of veterinary treatment and drugs revealed that the total loss due to retained placenta was 471 pounds per year for a 100-cow farm with an average incidence of the condition (6.6 per cent). For a 'problem' farm with a 30 per cent rate, the loss was 2139 pounds per year. A computer farm simulation model, based on a stochastic determination of events, was used to make calculations for circumstances closely resembling those on farms. A 6.6 per cent rate of retained placenta caused a small but significant decrease in net return on labour and management; however, a 30 per cent rate caused highly significant changes. The economic effects of retained placenta were similar in magnitude in herds of high or low productivity and high or low fertility. Sensitivity analysis showed that the greatest financial losses were caused by loss of milk production, followed by the number of animals suffering from complications. The financial losses in herds with an average rate of retained placenta were thus of limited economic importance and therapeutic measures alone should be adequate.(ABSTRACT TRUNCATED AT 250 WORDS)     

The control of heartwater on large-scale commercial and smallholder farms in Zimbabwe.

As part of a series of studies associated with the development of improved vaccines for heartwater (a tick-borne disease of ruminant livestock caused by Cowdria ruminantium), field surveys were carried out to assess losses associated with the disease and the costs associated with controlling it in the two main agro-ecological zones of Zimbabwe (lowveld and highveld) where heartwater is believed to be endemic and epidemic, respectively. In each zone, a cross-sectional study was performed in the main farming systems (smallholder (SH) and large-scale commercial (LSC) beef and dairy), followed by longitudinal studies in the same sectors to improve data accuracy for some parameters. Suspected heartwater-specific mortality in cattle was similar in all LSC sectors (p = 0.72) accounting for a median 1% mortality risk. Heartwater-specific mortality in SH areas was not assessed due to poor diagnostic ability of the farmers. Few LSC farms and SH households kept sheep; suspected heartwater-specific mortality in LSC sheep was 0.8% in the lowveld and 2.4% in the highveld. Goats were a major enterprise in SH areas but not on LSC farms. Suspected heartwater mortality in LSC goats was 0.8% at one site in the highveld and 17.5% on a farm in the lowveld. Application of acaricides was the major control method for heartwater and other tick-borne diseases on both SH and LSC farms. On LSC farms, plunge dipping was used most frequently and the number of acaricide applications ranged widely between 3 and 52 per year. The total cost of acaricides per head per annum was higher in highveld dairies than in highveld and lowveld beef enterprises (p = 0.03). In SH areas, cattle plunge dipping was conducted by the government with an average frequency of 8 +/- 2 (sd) immersions per annum in both the lowveld and highveld. The type of tick control on sheep and goats in all production systems was highly variable (ranging from none to hand removal or intensive acaricide treatment). Suspected heartwater cases on LSC farms were treated with tetracyclines; treatment was not reported in SH areas. Reported treatment costs were high (median Z$ 120) and highly variable (range Z$-833). Vaccination against heartwater with the live, blood-based vaccine was reported on only one LSC farm. LSC farms applying acaricide 30 or more times per year reported higher morbidity (p < 0.0001) and mortality (p < 0.0001) than farms applying acaricides less than 30 times a year. This finding supports the use of reduced tick control in the management of heartwater in Zimbabwe.     

Epidemiological aspects and financial impact of lumpy skin disease in Ethiopia

The financial cost of clinical Lumpy Skin Disease (LSD) and the financial benefit of its control through vaccination were studied based on questionnaire survey in Oromia region of Ethiopia from the perspective of livestock farmers. Production loss impacts for local zebu cattle were compared with those of Holstein Friesian (HF)/crossbred cattle in the study area. Annual cumulative incidence of LSD infection in HF/crossbred and local zebu cattle were 33.93% (95% CI: 30.92-36.94) and 13.41% (95% CI: 12.6-14.25) respectively and significantly different (p<0.05). Annual mortality was also significantly higher in HF/crossbred 7.43% (95% CI: 5.76-9.10) than in local zebu cattle 1.25% (95% CI: 0.98-1.52). The annual financial cost was calculated as the sum of the average production losses due to morbidity and mortality arising from milk loss, beef loss, traction power loss, and treatment and vaccination costs at the herd level. The financial cost in infected herds was estimated to be USD 6.43 (5.12-8) per head for local zebu and USD 58 (42-73) per head for HF/crossbred cattle. A partial budget analysis was used to estimate the financial benefit of an annual vaccination program in both the local zebu and HF/crossbred cattle farming systems. The marginal rate of return (MRR) gained from this control intervention was estimated to be 34 (3400%) and the net benefit per head was USD 1 for local zebu and USD 19 for HF/crossbred cattle. Vaccination thus enabled financial costs due to LSD to be reduced by 17% per head in local zebu herds and 31% per head in HF/crossbred herds. These results could provide guidance to producers and the government in their endeavors to control the disease.     

An outbreak of babesiosis (B. divergens) in a dairy herd comprising different age groups of cattle

Outbreaks of acute bovine babesiosis affecting several individuals within a herd are well known among veterinary practitioners and farmers within different parts of Sweden. Although outbreaks may not occur every year, they are feared by the farmers due to the unpredictability of the disease, its suddeness of onset, its rapid course, and the high mortality unless treated. Sporadic outbreaks of acute bovine babesiosis comprising several animals within a limited time period have been previously reported in Sweden (Linnaeus 1747, Bergman & Waxberg 1915, Heijbel 1928), in Finland (Hinderson 1928), in Norway as cited by Tambs-Lyche (1943), in the United Kingdom (Donnelly et al. 1970) and elsewhere within the area where B. divergens is distributed (Tambs-Lyche 1943, Purnell 1980). In all of these cases groups of animals had been transferred onto pastures where clinical cases of bovine babesiosis were known to occur from areas where the disease was rare or had never occurred; i.e. unexposed animals were transferred onto pastures with Babesia infected ticks. The farmers first became aware of this situation after the outbreak had occurred.     

Epidemiology of viral haemorrhagic disease and myxomatosis in a free-living population of wild rabbits

From January 1993 to June 1996, the epidemiology of myxomatosis and viral haemorrhagic disease (VHD) was studied in a free-living population of wild rabbits (Oryctolagus cuniculus) in Spain by means of serological surveys and radiotracking. Myxomatosis was endemic and associated with the breeding period. Its serological pattern was characterised by a 100 per cent prevalence of antibodies in adult rabbits and a rapid increase in antibodies in young rabbits in their first year. No mortality from myxomatosis was detected in adults, and mortality in young rabbits could not be estimated because of interference by predators and scavengers and the deaths of many radiotagged rabbits inside their burrows. VHD was also an endemic disease associated with the breeding period. Adults had a higher prevalence of antibodies against VHD than young rabbits, reaching values of 80 to 90 per cent. During the study, there was an increase in rabbit numbers as a result of a decrease in mortality from predation which was associated with an increase in mortality due to VHD and in the prevalence of antibodies to VHD. Mortality from VHD was lower in rabbits with VHD antibodies than in seronegative rabbits, but some mortality from the disease was also detected in seropositive rabbits. The annual mean mortality rate due to VHD in adult rabbits was estimated to be 21.8 per cent.     

Does control of bovine viral diarrhoea infection make economic sense?

AIM: To provide an economic analysis of the costs of control or eradication of bovine viral diarrhoea (BVD) against the estimated costs of the disease. METHODS: A decision-tree approach was adapted to an analysis of the costs of bovine viral diarrhoea virus (BVDV) infection and that of three main control options (vaccination, test-and-cull, and increased biosecurity) and their combinations, to the dairy industry in New Zealand. The model was based on an average herd of 322 milking cows. Endemic, epidemic and sporadic effects of BVDV infection were modelled in the herd, to derive an estimate of costs. RESULTS: The cost of BVDV infection to an infected average-sized dairy herd in New Zealand was estimated to be NZ $11,334 (or NZ $35.19 per cow) per annum, and NZ $48,311 over 10 years. Based on these calculations, the estimate of the annual cost of BVDV infection to the dairy industry in New Zealand was in excess of NZ $23 million per annum. While all of the control options required financial input, the rate of return compared with the cost of BVD, when viewed over a 10-year term, was as high as 123%. CONCLUSIONS: All control options offered considerable savings compared with the cost of BVD infection, and control is economically favourable. Uncertainty over the likely efficacy of the control options under field conditions in New Zealand would not allow a firm choice of one option over another at this stage, and more work on determining the efficacy of those control options in New Zealand is needed.     

Incidence of clinical mastitis in a cohort of British dairy herds

A three-year survey to determine the incidence of clinical mastitis and the associated bacteria in dairy herds in England and Wales is described. Escherichia coli was the predominant organism in each year. Streptococcus uberis and Staphylococcus aureus were important for part for each year. The annual incidence of mastitis declined from 54.6 cases per 100 cows in 1980 to 41.2 in 1982. The incidence increased with age and declined with increasing herd size. The culling rate due solely to mastitis was 3 per cent. Strep uberis was the pathogen most frequently isolated from clinical cases which occurred in the dry period. Thirty per cent of all cases recurred at least once and staphylococcal cases exhibited the highest frequency of recurrence.     

Changing incidence of bovine babesiosis in Ireland

Background

In Ireland bovine babesiosis is caused by the tick-borne blood parasite, Babesia divergens. A survey of veterinary practitioners and farmers in the 1980’s revealed an annual incidence of 1.7% associated with considerable economic losses. However, two subsequent surveys in the 1990’s indicated a decline in clinical babesiosis. Recent evidence from continental Europe suggests that, probably due to climate change, the distribution of the tick vector of B. divergens, Ixodes ricinus is extending to more northerly regions and higher altitudes. In addition, milder winters are thought to widen the window of tick activity.In order to determine whether any such changes have affected the incidence of bovine babesiosis in Ireland, a questionnaire survey of farmers and veterinarians was carried out and compared with data from previous surveys.

Results

Our survey indicates that while the incidence of clinical disease has continued to decline, cases can occur at any time of year. In contrast to previous surveys, affected farms were the same size as unaffected ones. There was no correlation between disease risk and the presence of deer on the land. Disease severity and mortality rates were increased because many infections were advanced by the time they were detected and treated.

Conclusion

While the precise reasons for the decline in the incidence of redwater are unknown, changes in agricultural practice are likely to be of importance. A reversal of the trend could be devastating, as vigilance among farmers and veterinarians is flagging and the national herd is losing its protective immunity to disease.     

Demography and dog-human relationships of the dog population in Zimbabwean communal lands

Dogs are Zimbabwe's primary vector for rabies, and the majority live in communal lands (traditional agropastoralist rural areas). In 1994, a household questionnaire survey was conducted to provide baseline data on the demography and dog-human relationships of the dogs in the communal lands. The survey showed that all the dogs were owned, and there was no evidence of a feral population. They were unrestricted and semi-dependent on people. The numbers of dogs per capita varied little in each communal land, resulting in higher dog densities in communal lands with higher human densities, and indicating that people were not intolerant of dogs at higher densities. The population turnover was rapid: the life expectancy of the dogs was 1.1 years, the mean age 2.0 years, and 71.8 per cent died in their first year. The population was heavily skewed towards juveniles, with 40.8 per cent aged less than 12 months. Despite the high juvenile mortality, the population was growing by 6.52 per cent per annum. It was estimated that in 1994 there were 1.36 million dogs in communal lands.     

Survey of canine babesiosis in South Africa

A questionnaire, designed to obtain qualitative information on a number of variables concerning canine babesiosis (biliary fever) in South Africa, was sent to 510 veterinary practices in late 1993. Of the 157 practices that responded, all were presented with cases of babesiosis and most were situated in Gauteng, the Western Cape and KwaZulu-Natal. Apart from the Western Cape, a winter-rainfall region, the prevalence of babesiosis cases in dogs was highest in summer. Most of the respondent practices treated between 1,000 and 5,000 sick dogs that included 100 to 500 babesiosis cases each year. Respondents identified cerebral babesiosis, enterorrhagia, 'red' or haemoconcentrated babesiosis, acute renal failure and pulmonary babesiosis or 'shock lung', amongst others, as the most prevalent forms of complicated ('atypical') babesiosis. Diminazene, imidocarb and trypan blue were the most popular antibabesials. Trypan blue was most often used in shocked patients, whereas diminazene and imidocarb were preferred when there was a high parasitaemia in the absence of shock. At least 19 antibabesial treatment regimens were used in practices. These comprised the use of single doses of antibabesial drugs; split doses with repeat injections, and combined drug variations, some of which are undesirable due to possible sterilisation of Babesia infection or potential toxicity. Side-effects were most commonly associated with imidocarb use. Ninety-six percent of respondents used supportive treatment (e.g. corticosteroids, vitamins and 'liver support') in all cases of babesiosis. The use of blood transfusion as supportive treatment varied according to practice and severity of the case. Most practices never cross-matched blood to be transfused, and transfusion reactions were rare. Diminazene was most frequently incriminated in cases where drug 'resistance' or relapses occurred. Cerebral and 'red' cases resulted in high mortality. Treatment of babesiosis costs the dog-owning public in South Africa more than R20 million each year. Information on the distribution and possible complicating role of Ehrlichia canis was obtained. Development of a vaccine was the first research priority identified.     

Economic cost of difficult calvings in the United Kingdom dairy herd

Information on the losses associated with lower milk production and reproductive performance, as well as information from a survey of uk dairy herds using beef semen was used to estimate the economic importance of calving difficulties in uk dairy herds. The survey covered information on cow and calf mortality, cow culling and the need for veterinary assistance, the incidences of which were related to the degree of calving difficulty experienced. The total cost of a slightly difficult calving was estimated to be approximately 110 pounds, and of a seriously difficult calving between 350 pounds and 400 pounds, depending on assumptions of the veterinary costs. However, the major costs were associated with the labour required at the delivery, the increase in the number of days open, and the costs associated with the deaths of cows and calves, and cow culling.     

Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina

A survey to estimate the potential demand for a bovine babesiosis and anaplasmosis vaccine was carried out by a postal questionnaire sent to 4407 veterinarians in the north and centre of Argentina. Twenty-three percent of the questionnaires (1047) were answered; 317 (7.2% of the total, 30% of those answered) pointed out the occurrence of the diseases and/or probable demand for the vaccine. The minimum and maximum demands were 407,892 and 982,300 doses for anaplasmosis, and 272,496 and 631,400 doses for babesiosis, respectively. The results presented from here onwards are based on the minimum demand. Sixty-eight and 48% of the anaplasmosis and babesiosis vaccine demand, respectively, came from veterinarians living in the Boophilus microplus-free area, while the remainder came from the tick-infested area, reflecting the fact that many farm owners from the tick-infested area seek professional assistance from veterinarians living in the tick-free area. Most of the demand for both vaccines was aimed at breeding cattle (77.2%), 14.5% at dairy cattle and the rest at studs (8.3%). Veterinarians living in the tick-infested area demanded vaccine for breeding cattle in a higher proportion than veterinarians from the tick-free area, whose demand was greater for dairy cattle. In the tick-free area, the demand for anaplasmosis vaccine was twice that for babesiosis vaccine, whereas in the tick-infested area the demand was equal. This agrees with the fact that the anaplasmosis-stricken area extends beyond the tick-infested region. Sixty percent of the respondents preferred a vaccine frozen in liquid nitrogen, whilst the rest preferred a refrigerated one, the first group accounted for 73% of the total demand. Fifty-six percent of the demand occurred between March and June with the peak in April, which reflects the main weaning date. The elasticity of the demand is discussed in relation to the probable benefits to be accrued by the farmers who make use of it. The annual mortality rates due to both babesiosis and anaplasmosis were estimated at 1.5 and 3.5% in the milk herds of Salta and Tucumán, respectively. In the beef herds of these two provinces, the mortality rate due to both diseases has been estimated at 3.5%. Using these figures and current prices, the systematic application of the vaccine in calves would render a benefit-cost ratio between 4.6 and 9.0, which would warrant its use in the herds of the areas at risk, i.e. in enzootic instability.